Navigation Links
Targeting the Ewing sarcoma family of tumors
Date:6/30/2011

NEW YORK The Max Cure Foundation and the Samuel Waxman Cancer Research Foundation have partnered to establish a fund in pediatric cancer research. With that goal in mind, the two Foundations are proud to announce the award of $100,000 to Erwin G. Van Meir, Ph.D., of Emory University School of Medicine in Atlanta. Van Meir's research aims to reprogram Ewing sarcoma using a small molecule that will target the Ewing sarcoma family of tumors (ESFT) oncoprotein.

Ewing sarcoma, a type of cancer that forms in the bone or soft tissue, affects primarily young children and adolescents. Though current treatment options have prolonged five-year survival rates in patients, many face long-term affects from surgery, chemotherapy and radiation, including risk of second cancers from therapy. For patients whose disease has spread to other organs, there's a lack of effective treatment options. In addition, for some survivors, the disease can recur.

Van Meir and his colleagues propose to reprogram the ESFT cancer stem cells using a small molecule known as KCN1, which targets the oncoprotein found in the genetic signature of ESFT. Their research will identify a new class of drugs to induce cell death and stop the proliferation of Ewing sarcoma stem cells.

"Van Meir's research offers patients the real promise of a cure one day by identifying the root cause of cancer and eradicating the cancer stem cell, which falls in line with the mission of the Foundation" said Samuel Waxman, M.D., the Founder and the Scientific Director of the SWCRF.

"My grandson Max, who, on the eve of his fourth birthday was diagnosed with an extremely rare form of B-cell Lymphoma, was the inspiration for The Max Cure Foundation," said Richard Plotkin, vice chairman of The Max Cure Foundation. "As Max bravely endured two years of treatment which ultimately led to his remissionmy family went into action to raise funds for pediatric cancer research. This grant is the first of three collaborative grants we're committed to sponsoring with SWCRF so that other children will not have to experience long, painful and invasive cancer treatments."


'/>"/>

Contact: Jenny Song
jsong@waxmancancer.org
212-867-4502
Samuel Waxman Cancer Research Foundation
Source:Eurekalert

Related medicine news :

1. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
2. Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables
3. NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB
4. Targeting top 911 callers can trim cost, improve patient care
5. Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial
6. New program targeting whole-person health care gets major grant
7. Targeting nicotine receptors to treat cognitive impairments in schizophrenia
8. Scientists announce new advance with potential for future cancer targeting
9. Investment in CRC screening targeting pre-medicare population could cut medicare treatment costs
10. Targeting hit-and-run cancer viruses
11. Targeting flight-or-fight hormone response to combat heart failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Watsonville, California (PRWEB) , ... May 04, 2016 ... ... powerful formulation of foundational nutrients that supports cellular and metabolic health. This synergistic ... and 400 mg free-form curcumin, along with 150 mg of reduced glutathione and ...
(Date:5/4/2016)... ... , ... Natalie Jill is a well respected lifestyle mentor and ... launch of her new book: Natalie Jill’s 7 Day Jump Start: Unprocess Your Diet ... start a new healthy lifestyle featuring simple recipes using MitoXcell’s raw cacao formula. ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco Products has announced the ... dual-light flashlights in models NSP-9842XL and NSR-9844XL . , First previewed at ... uses 2 included CR-123 batteries to produce up to 650 lumens in a ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... ankles, and elbows. Engineered with athletes in mind, OMNIFORCE offers high-performance, less ... ineffective circular knitting, common in the industry) produces premium flat-knit construction with ...
(Date:5/4/2016)... KS (PRWEB) , ... May 04, 2016 , ... ... Transtem™ Patient 2016, a powerful cellular therapy software application that helps blood ... treatments to patients. , Since Transtem’s initial launch, Mediware has continued to enhance ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Myeloma Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Multiple ... Myeloma market valuations and forecast, Multiple Myeloma ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute lymphocytic Leukemia Market and ... their offering.       (Logo: ... Lymphocytic Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Lymphocytic Leukemia epidemiology, ...
(Date:5/3/2016)... acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and ... ... ... ... ...
Breaking Medicine Technology: